Suppr超能文献

美国肝内胆管癌、肝外胆管癌和肝细胞癌的地理差异。

Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.

作者信息

Altekruse Sean F, Petrick Jessica L, Rolin Alicia I, Cuccinelli James E, Zou Zhaohui, Tatalovich Zaria, McGlynn Katherine A

机构信息

Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, United States of America.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.

出版信息

PLoS One. 2015 Apr 2;10(3):e0120574. doi: 10.1371/journal.pone.0120574. eCollection 2015.

Abstract

BACKGROUND

Intrahepatic (ICC) and extrahepatic cholangiocarcinomas (ECC) are tumors that arise from cholangiocytes in the bile duct, but ICCs are coded as primary liver cancers while ECCs are coded as biliary tract cancers. The etiology of these tumors is not well understood. It has been suggested that the etiology of ICC is more similar to that of another type of liver cancer, hepatocellular carcinoma (HCC), than to the etiology of ECC. If this is true, geographic incidence patterns and trends in ICC incidence should be more similar to that of HCC than ECC.

METHODS

To examine this hypothesis, data from the North American Association of Central Cancer Registries Cancer in North America data file were analyzed. Incidence rates and joinpoint trends were calculated by demographic subgroup. County-level incidence rates were mapped.

RESULTS

Overall incidence rates, racial distribution, male:female ratio, and peak ages were more similar between ICC and ECC than with HCC. During 2000-2009, average annual incidence rates of ECC increased. During 2005-2009, average annual ICC incidence rates also increased. High rates for all three cancer sites were found in the Pacific region, particularly Hawaii and Alaska. Rates of ICC and ECC were also high in the Northeast and the upper Midwest, while rates of HCC were high in the South.

CONCLUSIONS

Demographic patterns and geographical variation were more closely related between ICC and ECC than HCC, suggesting that the etiology of ICC and ECC may be similar. Increasing rates of both tumors suggest that further etiology studies are warranted.

摘要

背景

肝内胆管癌(ICC)和肝外胆管癌(ECC)是起源于胆管上皮细胞的肿瘤,但ICC被编码为原发性肝癌,而ECC被编码为胆道癌。这些肿瘤的病因尚不清楚。有人提出,ICC的病因与另一种肝癌——肝细胞癌(HCC)的病因相比,与ECC的病因更相似。如果这是真的,那么ICC发病率的地理分布模式和趋势应该与HCC比与ECC更相似。

方法

为检验这一假设,分析了北美中央癌症登记协会北美癌症数据文件中的数据。按人口亚组计算发病率和连接点趋势。绘制了县级发病率地图。

结果

ICC和ECC之间的总体发病率、种族分布、男女比例和发病高峰年龄比与HCC之间更相似。在2000 - 2009年期间,ECC的年均发病率有所上升。在2005 - 2009年期间,ICC的年均发病率也有所上升。在太平洋地区,特别是夏威夷和阿拉斯加,这三种癌症的发病率都很高。ICC和ECC在东北部和中西部上游地区的发病率也很高,而HCC在南部地区的发病率很高。

结论

ICC和ECC之间的人口统计学模式和地理差异比与HCC之间的关系更密切,这表明ICC和ECC的病因可能相似。两种肿瘤发病率的上升表明有必要进一步开展病因学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb0/4383424/e204cfe6255f/pone.0120574.g001.jpg

相似文献

2
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6.
3
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.
4
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
Cancer. 2020 Jun 1;126(11):2666-2678. doi: 10.1002/cncr.32803. Epub 2020 Mar 4.
5
Intrahepatic cholangiocarcinoma: new insights in pathology.
Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22.
6
Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):886-894. doi: 10.1158/1055-9965.EPI-20-1241. Epub 2021 Feb 24.
7
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203. doi: 10.1158/1055-9965.EPI-05-0811.
8
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
Oncologist. 2016 May;21(5):594-9. doi: 10.1634/theoncologist.2015-0446. Epub 2016 Mar 21.
9
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195.
10
Have incidence rates of liver cancer peaked in the United States?
Cancer. 2020 Jul 1;126(13):3151-3155. doi: 10.1002/cncr.32794. Epub 2020 Apr 15.

引用本文的文献

1
Updated cholangiocarcinoma incidence trends and projections in Thailand by region based on data from four population-based cancer registries.
Lancet Reg Health Southeast Asia. 2025 Mar 29;35:100569. doi: 10.1016/j.lansea.2025.100569. eCollection 2025 Apr.
3
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes.
Lancet Reg Health Am. 2024 Nov 25;40:100952. doi: 10.1016/j.lana.2024.100952. eCollection 2024 Dec.
4
Widening Health Disparities: Increasing Cholangiocarcinoma Incidence in an Underserved Population.
Gastro Hep Adv. 2022 Feb 3;1(2):180-185. doi: 10.1016/j.gastha.2021.12.003. eCollection 2022.
5
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.
Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946.
6
The role of living donor liver transplantation in treating intrahepatic cholangiocarcinoma.
Front Oncol. 2024 May 21;14:1404683. doi: 10.3389/fonc.2024.1404683. eCollection 2024.
8
Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes.
Proc (Bayl Univ Med Cent). 2023 Sep 14;36(6):700-704. doi: 10.1080/08998280.2023.2254196. eCollection 2023.

本文引用的文献

1
Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Am J Gastroenterol. 2014 Apr;109(4):542-53. doi: 10.1038/ajg.2014.11. Epub 2014 Feb 11.
2
Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review.
J Gastroenterol Hepatol. 2012 Oct;27(10):1561-8. doi: 10.1111/j.1440-1746.2012.07207.x.
3
Epidemiology of viral hepatitis and hepatocellular carcinoma.
Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061.
4
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
J Hepatol. 2012 Apr;56(4):848-54. doi: 10.1016/j.jhep.2011.11.015. Epub 2011 Dec 13.
5
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):591-9. doi: 10.1158/1055-9965.EPI-10-1183. Epub 2011 Jan 25.
6
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.
7
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6.
8
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23.
9
A new method of estimating United States and state-level cancer incidence counts for the current calendar year.
CA Cancer J Clin. 2007 Jan-Feb;57(1):30-42. doi: 10.3322/canjclin.57.1.30.
10
Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States.
Liver Int. 2006 Nov;26(9):1047-53. doi: 10.1111/j.1478-3231.2006.01350.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验